Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Axitinib treatment turned a man's grey hair back to black.

Sonidegib often causes hair loss, and LC-OCT helps identify early signs.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Vitamin D may help protect against nonmelanoma skin cancer.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.

Patients with skin cancer on the scalp and ear in Mexico have specific features and results from their treatments.